BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19890396)

  • 21. Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades.
    Bainomugisa A; Lavu E; Hiashiri S; Majumdar S; Honjepari A; Moke R; Dakulala P; Hill-Cawthorne GA; Pandey S; Marais BJ; Coulter C; Coin L
    Microb Genom; 2018 Feb; 4(2):. PubMed ID: 29310751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Polymorphisms Associated with Multidrug-Resistant Tuberculosis by Whole Genomic Sequencing: A Preliminary Report from Mexico.
    Zenteno-Cuevas R; Fernandez E; Viveros D; Madrazo-Moya CF; Cancino-Muñoz I; Comas I; Gonzalez-Covarrubias V; Barbosa-Amezcua M; Cuevas-Cordoba B
    Microb Drug Resist; 2020 Jul; 26(7):732-740. PubMed ID: 31874045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-nucleotide variations associated with Mycobacterium tuberculosis KwaZulu-Natal strains.
    Das S; Yennamalli RM; Vishnoi A; Gupta P; Bhattacharya A
    J Biosci; 2009 Sep; 34(3):397-404. PubMed ID: 19805901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Said HM; Peters RPH; Sekyere JO; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant
    Ghajavand H; Kargarpour Kamakoli M; Khanipour S; Pourazar Dizaji S; Masoumi M; Rahimi Jamnani F; Fateh A; Yaseri M; Siadat SD; Vaziri F
    Antimicrob Resist Infect Control; 2019; 8():70. PubMed ID: 31073401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
    Gandhi NR; Weissman D; Moodley P; Ramathal M; Elson I; Kreiswirth BN; Mathema B; Shashkina E; Rothenberg R; Moll AP; Friedland G; Sturm AW; Shah NS
    J Infect Dis; 2013 Jan; 207(1):9-17. PubMed ID: 23166374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
    Roa MB; Tablizo FA; Morado EKD; Cunanan LF; Uy IDC; Ng KCS; Manalastas-Cantos KG; Reyes JM; Ganchua SKC; Ang CF; Kato-Maeda M; Cattamanchi A; Karaoz U; Destura RV; Lluisma AO
    J Glob Antimicrob Resist; 2018 Dec; 15():239-245. PubMed ID: 30130640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm.
    Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y; Bo D; Lin X; Chen T; He T; Lin Y
    BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study.
    Makhado NA; Matabane E; Faccin M; Pinçon C; Jouet A; Boutachkourt F; Goeminne L; Gaudin C; Maphalala G; Beckert P; Niemann S; Delvenne JC; Delmée M; Razwiedani L; Nchabeleng M; Supply P; de Jong BC; André E
    Lancet Infect Dis; 2018 Dec; 18(12):1350-1359. PubMed ID: 30342828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa.
    Nelson KN; Shah NS; Mathema B; Ismail N; Brust JCM; Brown TS; Auld SC; Omar SV; Morris N; Campbell A; Allana S; Moodley P; Mlisana K; Gandhi NR
    J Infect Dis; 2018 Nov; 218(12):1964-1973. PubMed ID: 29961879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide polymorphisms in efflux pumps genes in extensively drug resistant Mycobacterium tuberculosis isolates from Pakistan.
    Kanji A; Hasan R; Ali A; Zaver A; Zhang Y; Imtiaz K; Shi W; Clark TG; McNerney R; Phelan J; Rao S; Shafiq S; Hasan Z
    Tuberculosis (Edinb); 2017 Dec; 107():20-30. PubMed ID: 29050768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.
    Chisompola NK; Streicher EM; Muchemwa CMK; Warren RM; Sampson SL
    BMC Infect Dis; 2020 May; 20(1):344. PubMed ID: 32404119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
    Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.
    Kim HJ; Kwak HK; Lee J; Yun YJ; Lee JS; Lee MS; Min SY; Park SK; Kang HS; Maeng YH; Kim SY; Kim SY; Kook YH; Kim YR; Lee KH
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):98-103. PubMed ID: 22236853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.